Literature DB >> 11742533

Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors.

Guy Verrijdt1, Annemie Haelens, Erik Schoenmakers, Wilfried Rombauts, Frank Claessens.   

Abstract

We performed a comparative analysis of the effect of high-mobility group box protein 1 (HMGB1) on DNA binding by the DNA-binding domains (DBDs) of the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. The affinity of the DBDs of the different receptors for the tyrosine aminotransferase glucocorticoid response element, a classical high-affinity binding element, was augmented up to 7-fold by HMGB1. We found no major differences in the effects of HMGB1 on DNA binding between the different steroid hormone receptors. In transient transfection assays, however, HMGB1 significantly enhances the activity of the glucocorticoid and progesterone receptors but not the androgen or mineralocorticoid receptor. We also investigated the effect of HMGB1 on the binding of the androgen receptor DBD to a subclass of directly repeated response elements that is recognized exclusively by the androgen receptor and not by the glucocorticoid, progesterone or mineralocorticoid receptor. Surprisingly, a deletion of 26 amino acid residues from the C-terminal extension of the androgen receptor DBD does not influence DNA binding but destroys its sensitivity to HMGB1. Deletion of the corresponding fragment in the DBDs of the glucocorticoid, progesterone and mineralocorticoid receptor destroyed their DNA binding. This 26-residue fragment is therefore essential for the influence of HMGB1 on DNA recognition by all steroid hormone receptors that were tested. However, it is dispensable for DNA binding by the androgen receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11742533      PMCID: PMC1222283          DOI: 10.1042/0264-6021:3610097

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Nuclear receptor coregulators: cellular and molecular biology.

Authors:  N J McKenna; R B Lanz; B W O'Malley
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2.

Authors:  V Aidinis; T Bonaldi; M Beltrame; S Santagata; M E Bianchi; E Spanopoulou
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

3.  Architectural regulations and Hmg1.

Authors:  A P Wolffe
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

4.  Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.

Authors:  E Schoenmakers; P Alen; G Verrijdt; B Peeters; G Verhoeven; W Rombauts; F Claessens
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

5.  High mobility group protein 1 interacts specifically with the core domain of human TATA box-binding protein and interferes with transcription factor IIB within the pre-initiation complex.

Authors:  M Sutrias-Grau; M E Bianchi; J Bernués
Journal:  J Biol Chem       Date:  1999-01-15       Impact factor: 5.157

6.  The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice.

Authors:  S Calogero; F Grassi; A Aguzzi; T Voigtländer; P Ferrier; S Ferrari; M E Bianchi
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

7.  Specific androgen receptor activation by an artificial coactivator.

Authors:  X Sui; K S Bramlett; M C Jorge; D A Swanson; A C von Eschenbach; G Jenster
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

8.  HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells.

Authors:  C C Zhang; S Krieg; D J Shapiro
Journal:  Mol Endocrinol       Date:  1999-04

9.  Apparent coactivation due to interference of expression constructs with nuclear receptor expression.

Authors:  K Hofman; J V Swinnen; F Claessens; G Verhoeven; W Heyns
Journal:  Mol Cell Endocrinol       Date:  2000-10-25       Impact factor: 4.102

10.  High-resolution solution structure of the retinoid X receptor DNA-binding domain.

Authors:  S M Holmbeck; M P Foster; D R Casimiro; D S Sem; H J Dyson; P E Wright
Journal:  J Mol Biol       Date:  1998-08-14       Impact factor: 5.469

View more
  34 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

2.  Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity.

Authors:  Junjiang Fu; Jun Jiang; Jiwen Li; Shanshan Wang; Guang Shi; Qin Feng; Eileen White; Jun Qin; Jiemin Wong
Journal:  J Biol Chem       Date:  2009-01-05       Impact factor: 5.157

3.  A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels.

Authors:  Tamzin M Tanner; Sarah Denayer; Bart Geverts; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Lien Spans; Vanessa Dubois; Adriaan B Houtsmuller; Frank Claessens; Annemie Haelens
Journal:  Cell Mol Life Sci       Date:  2010-02-26       Impact factor: 9.261

4.  Expression of Tubb3, a beta-tubulin isotype, is regulated by androgens in mouse and rat Sertoli cells.

Authors:  Karel De Gendt; Evi Denolet; Ariane Willems; Veerle W Daniels; Liesbeth Clinckemalie; Sarah Denayer; Miles F Wilkinson; Frank Claessens; Johannes V Swinnen; Guido Verhoeven
Journal:  Biol Reprod       Date:  2011-07-06       Impact factor: 4.285

5.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

Authors:  Sarah C Roemer; Douglas C Donham; Lori Sherman; Vickie H Pon; Dean P Edwards; Mair E A Churchill
Journal:  Mol Endocrinol       Date:  2006-08-24

Review 6.  Structural and functional analysis of domains of the progesterone receptor.

Authors:  Krista K Hill; Sarah C Roemer; Mair E A Churchill; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-07-22       Impact factor: 4.102

Review 7.  HMGB1 in hormone-related cancer: a potential therapeutic target.

Authors:  Madhuwanti Srinivasan; Souresh Banerjee; Allison Palmer; Guoxing Zheng; Aoshuang Chen; Maarten C Bosland; André Kajdacsy-Balla; Ramaswamy Kalyanasundaram; Gnanasekar Munirathinam
Journal:  Horm Cancer       Date:  2014-04-10       Impact factor: 3.869

8.  HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling.

Authors:  Qing-Wu Yang; Feng-Lin Lu; Yu Zhou; Lin Wang; Qi Zhong; Sen Lin; Jing Xiang; Jing-Cheng Li; Chuan-Qing Fang; Jing-Zhou Wang
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-11       Impact factor: 6.200

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

10.  Use of phage display to identify novel mineralocorticoid receptor-interacting proteins.

Authors:  Jun Yang; Peter J Fuller; James Morgan; Hirotaka Shibata; Donald P McDonnell; Colin D Clyne; Morag J Young
Journal:  Mol Endocrinol       Date:  2014-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.